Back to 
MAI Capital Management
MAI Capital Management
CNSP4 quarters
Position history for MAI Capital Management's holdings in CNS PHARMACEUTICALS INC
No. MAI Capital Management exited its CNSP (CNS Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 3 shares worth $8. MAI Capital Management first reported CNSP in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$27
Total Shares Change
-3
Quarter-by-Quarter History
Other major holders of CNSP: UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, VANGUARD CAPITAL MANAGEMENT LLC